ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYRNovember 12, 2025 7:39 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the "Class Period"), of t ...

New York, New York--(Newsfile Corp. - November 12, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hormel Foods Corporation (NYSE: HRL) resulting from allegations that Hormel may have issued materially misleading business information to the investing public.SO WHAT: If you purchased Hormel securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingen ...

NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the “Class Period”), of the important December 29, 2025 lead plaintiff deadline. SO WHAT: If you purchased Avantor common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WH ...

NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of common stock of Cepton, Inc. (NASDAQ: CPTN) between July 29, 2024 and January 6, 2025, both dates inclusive (the “Class Period”), of the important December 8, 2025 lead plaintiff deadline. SO WHAT: If you purchased or sold Cepton common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fe ...

诉讼案件概述 - 罗森律师事务所提醒在2022年2月23日至2025年7月30日期间购买百特国际公司普通股的投资者，首席原告截止日期为2025年12月15日 [1] - 投资者可能有权通过风险代理收费安排获得补偿，无需支付任何自付费用 [2] 诉讼指控内容 - 指控百特国际未能披露其Novum IQ大容量输液泵存在系统性缺陷，导致广泛故障，包括输液不足、输液过量及完全不输液，使患者面临严重受伤或死亡风险 [5] - 指控百特国际已收到多起因这些缺陷导致的设备故障、伤害和死亡通知，但其通过客户警报解决问题的尝试是补救措施不足 [5] - 指控由于上述问题，存在客户被指示停用现有Novum输液泵以及百特完全暂停该产品新销售的风险 [5] - 指控基于前述原因，百特国际关于Novum输液泵安全性、有效性、产品推广、客户反馈和销售前景的陈述存在重大虚假和误导性 [5] 律所背景信息 - 罗森律师事务所专注于证券集体诉讼和股东衍生诉讼，其达成过针对中国公司的史上最大证券集体诉讼和解 [4] - 该律所被ISS证券集体诉讼服务评为2017年证券集体诉讼和解数量第一名，自2013年以来每年排名前四，为投资者追回数亿美元 [4] - 2019年，该律所为投资者确保了超过4.38亿美元的赔偿 [4]

New York, New York--(Newsfile Corp. - November 11, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Western Alliance Bancorporation (NYSE: WAL) resulting from allegations that Western Alliance Bancorporation may have issued materially misleading business information to the investing public.SO WHAT: If you purchased Western Alliance Bancorporation securities you may be entitled to compensation without payment of ...

ROSEN, A LEADING LAW FIRM, Encourages Marex Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRXNovember 11, 2025 2:20 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 11, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025, both dates inclusive (the "Class Period"), of the important December 8, 202 ...

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Nidec Corporation Investors to Inquire About Securities Class Action Investigation - NJDCYNovember 11, 2025 12:15 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 11, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Nidec Corporation (OTC: NJDCY) resulting from allegations that Nidec Corporation may have ...

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TLXNovember 11, 2025 12:10 PM EST | Source: The Rosen Law Firm PANew York, New York--(Newsfile Corp. - November 11, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) betwee ...

文章核心观点 - 罗森律师事务所宣布针对德康医疗（DexCom, Inc）在2024年7月26日至2025年9月17日期间购入其证券的投资者提起集体诉讼，指控公司在上述期间发布了虚假和/或误导性陈述[1][5] - 诉讼核心指控德康医疗对其连续血糖监测（CGM）系统进行了未经美国食品药品监督管理局（FDA）授权的重大设计变更，导致设备可靠性下降并带来健康风险，公司因此面临监管审查及财务声誉损害[5] 集体诉讼详情 - 诉讼类别期（Class Period）为2024年7月26日至2025年9月17日，主要原告申请截止日期为2025年12月29日[1][3] - 投资者可通过指定网站、电话或邮件方式加入集体诉讼，且无需支付任何自付费用，通过风险代理收费安排可能获得补偿[2][3][6] - 在集体诉讼类别未获法院认证前，投资者未被律师代表，可选择自行聘请律师或作为缺席成员[7] 针对德康医疗的指控内容 - 指控德康医疗对G6和G7连续血糖监测系统进行了未经FDA授权的重大设计变更[5] - 指控上述设计变更导致G6和G7设备可靠性低于前代产品，对依赖设备获取准确血糖读数的用户构成重大健康风险[5] - 指控公司夸大了G7设备的可靠性、准确性和功能性增强效果，并淡化了受影响的G7设备所引发问题的真实严重性和健康风险[5] 律师事务所背景 - 罗森律师事务所专注于证券集体诉讼和股东派生诉讼，代表全球投资者[4] - 该所曾达成针对中国公司的史上最大证券集体诉讼和解，并于2017年被ISS证券集体诉讼服务评为和解数量第一，自2013年起每年排名前四[4] - 该所已为投资者挽回数亿美元损失，仅在2019年就为投资者获得超过4.38亿美元赔偿[4]